Executive Director, Asset Team Lead (AI)

Location: Remote, United States, with required periodic travel

Company

hirify.global is a clinical-stage TechBio company developing investigational medicines through the AI-native hirify.global OS, which integrates biology, chemistry, and clinical development.

What you will do

• Define and drive strategy for small-molecule clinical programs in oncology and immunology/inflammation.
• Integrate competitive positioning, mechanistic differentiation, biomarker strategy, and patient segmentation into portfolio decisions.
• Translate hirify.global OS, ClinTech, proprietary data, and computational insights into strategic asset advantages.
• Develop and pressure-test competitive narratives for clinical assets to support leadership decisions, partnerships, and investor communications.
• Partner with clinical development, business development, finance, discovery, platform, and other functional leaders on resource allocation and portfolio priorities.

Requirements

• PhD in life sciences or a related scientific discipline.
• 10+ years of biotech or pharmaceutical experience with a record of strategic asset leadership through clinical stage-gates.
• Deep expertise in small-molecule therapeutics for oncology and immunology/inflammation.
• Experience using computational approaches and data-driven platforms for asset strategy and clinical decision-making.
• Ability to build and communicate strategic and competitive cases integrating mechanistic, regulatory, market, and financial considerations.
• Exceptional executive presence and ability to present clear recommendations to senior leaders and external partners.

Nice to have

• Expertise in rare disease.

Culture & Benefits

• Remote work from the United States with periodic travel.
• Annual bonus eligibility.
• Equity compensation.
• Comprehensive benefits package.
• Cross-functional environment focused on AI-powered drug discovery, rigorous analysis, ownership, and patient impact.